Publications, Pharmaceutical

Investigating Storage Options for Pressurized Metered Dose Inhalers

Selecting an appropriate closure system for a pressurized metered dose inhaler is critical for the maintenance of product integrity and safety, over an extended period.

This paper describes a study of the performance of 12 different valve configurations with a fluticasone propionate/salmeterol xinafoate formulation. Via a Design of Experiments study, accelerated testing was carried out by subjecting the samples to extreme stress (50oC/75%RH) over a period of two weeks. A comparison with data generated over a period of 3 months under more benign storage conditions indicates that the shorter testing protocol provides useful, relevant data. It could therefore be used to efficiently inform valve configuration choice in the early stages of product development, to screen more options in a short timeframe and accelerate progress.

Download Publication
8 May 2021

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More

This Might Also Be of Interest

2 Jun 2021

Aptar Pharma discusses how digital solutions improve patient outcomes

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
15 May 2021

Demonstrating bioequivalence for generic fluticasone propionate OINDPs

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
15 May 2021

Evaluation of Albuterol Sulfate with Low Global Warming Potential Propellants

Publications, Pharmaceutical, Product Solutions, Sustainability, Device Innovations, Brand Differentiation

Read More
8 May 2021

Investigating Storage Options for Pressurized Metered Dose Inhalers

Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations

Read More
1 10 11 12 13 14 19
Back To Top